Eyexora to Host Two-Part Key Opinion Leader Webinar Series

NEW YORK & SINGAPORE--(BUSINESS WIRE)--Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced that it will host a key opinion leader (KOL) webinar series featuring globally recognized experts in ophthalmology. The webinar series will be held in two parts and made available on Eyexora’s investors page. Details below: Part 1: Advancing Sustained, Interventional Office-Based Therapies for Ocular Surface Disease The webinar